Stuart L. Schreiber

3.2k total citations · 1 hit paper
12 papers, 2.7k citations indexed

About

Stuart L. Schreiber is a scholar working on Molecular Biology, Oncology and Biomedical Engineering. According to data from OpenAlex, Stuart L. Schreiber has authored 12 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 5 papers in Oncology and 2 papers in Biomedical Engineering. Recurrent topics in Stuart L. Schreiber's work include Signaling Pathways in Disease (4 papers), Peptidase Inhibition and Analysis (3 papers) and Innovative Microfluidic and Catalytic Techniques Innovation (2 papers). Stuart L. Schreiber is often cited by papers focused on Signaling Pathways in Disease (4 papers), Peptidase Inhibition and Analysis (3 papers) and Innovative Microfluidic and Catalytic Techniques Innovation (2 papers). Stuart L. Schreiber collaborates with scholars based in United States, Japan and South Korea. Stuart L. Schreiber's co-authors include Andrzej Gałat, Matthew W. Harding, David Uehling, Robert F. Standaert, Gregory L. Verdine, Gerald R. Crabtree, David Fiorentino, Xiao-Feng Zheng, Jie Chen and Julian A. Simon and has published in prestigious journals such as Nature, Cell and Gastroenterology.

In The Last Decade

Stuart L. Schreiber

12 papers receiving 2.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A receptor for the immuno-suppressant FK506 is a cis–trans peptidyl-prolyl isomerase

1989 1.2k citations Matthew W. Harding, Andrzej Gałat et al. Nature profile →

Peers

Countries citing papers authored by Stuart L. Schreiber

Since Specialization

Citations

This map shows the geographic impact of Stuart L. Schreiber's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stuart L. Schreiber with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stuart L. Schreiber more than expected).

Fields of papers citing papers by Stuart L. Schreiber

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stuart L. Schreiber. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stuart L. Schreiber. The network helps show where Stuart L. Schreiber may publish in the future.

Co-authorship network of co-authors of Stuart L. Schreiber

This figure shows the co-authorship network connecting the top 25 collaborators of Stuart L. Schreiber. A scholar is included among the top collaborators of Stuart L. Schreiber based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stuart L. Schreiber. Stuart L. Schreiber is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

#	Work	Indexed citations
1	A Cell-Based, High-Throughput Screen for Small Molecule Regulators of Hepatitis C Virus Replication 2006 ·Gastroenterology ·Sun Suk Kim, Lee F. Peng, Wenyu Lin, (unknown), Naoya Sakamoto, Stuart L. Schreiber, Raymond T. Chung	70
2	PERSPECTIVE 2003 ·Chemical & Engineering News ·Stuart L. Schreiber	214
3	The PIK-related kinases intercept conventional signaling pathways 1999 ·Chemistry & Biology ·Finny G. Kuruvilla, Stuart L. Schreiber	60
4	Small molecule-dependent genetic selection in stochastic nanodroplets as a means of detecting protein-ligand interactions on a large scale 1997 ·Chemistry & Biology ·Allen Borchardt, Stephen D. Liberles, Stephen R. Biggar, Gerald R. Crabtree, Stuart L. Schreiber	52
5	Fiber-derived butyrate and the prevention of colon cancer 1997 ·Chemistry & Biology ·Christian A. Hassig, Jeffrey K. Tong, Stuart L. Schreiber	75
6	A miniaturized arrayed assay format for detecting small molecule-protein interactions in cells 1997 ·Chemistry & Biology ·(unknown), Rebecca J. Jackman, George M. Whitesides, Stuart L. Schreiber	63
7	TOR kinase domains are required for two distinct functions, only one of which is inhibited by rapamycin 1995 ·Cell ·Xiao-Feng Zheng, David Fiorentino, Jie Chen, Gerald R. Crabtree, Stuart L. Schreiber	243
8	Grb2 SH3 binding to peptides from Sos: evaluation of a general model for SH3-ligand interactions 1995 ·Chemistry & Biology ·Julian A. Simon, Stuart L. Schreiber	70
9	Immunophilin-sensitive protein phosphatase action in cell signaling pathways 1992 ·Cell ·Stuart L. Schreiber	300
10	A rapamycin-selective 25-kDa immunophilin 1992 ·Biochemistry ·Andrzej Gałat, William S. Lane, Robert F. Standaert, Stuart L. Schreiber	107
11	Molecular cloning and overexpression of the human FK506-binding protein FKBP 1990 ·Nature ·Robert F. Standaert, Andrzej Gałat, Gregory L. Verdine, Stuart L. Schreiber	279
12	A receptor for the immuno-suppressant FK506 is a cis–trans peptidyl-prolyl isomerase breakdown → 1989 ·Nature ·Matthew W. Harding, Andrzej Gałat, David Uehling, Stuart L. Schreiber	1154

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact